A recent study published in Nature Aging reveals that life expectancy growth has slowed dramatically, with only 5% of children born since 2010 projected to live to 100. Global life expectancy has historically increased due to improvements in medicine, nutrition, and sanitation, but this trend is no longer as strong.
Research shows that the global slowdown is mainly due to increased chronic health conditions such as heart disease, diabetes and obesity, particularly in high-income countries [1]. Public health advancements no longer have the same impact and infectious diseases are no longer the primary drivers of mortality.
The COVID-19 pandemic also contributed to a temporary decline in life expectancy, although it only accelerated an already-existing trend [2].
Key factors behind this deceleration include socio-economic disparities, limited access to healthcare and growing inequality. Low- and middle-income countries, in particular, face barriers that prevent their populations from benefiting equally from medical advancements.
Even in high-income regions, increasing inequality and lifestyle-related illnesses hamper life expectancy growth [3].
The study concludes that improving public health efforts focused on aging-related diseases and addressing disparities in healthcare access are essential steps to revitalize life expectancy gains. This reassures us that we can make significant progress in improving life expectancy with the right strategies.
This marks a significant shift in global longevity trends, raising concerns about future progress. However, it also presents an opportunity for international collaboration in addressing the factors contributing to this slowdown, giving us hope for a healthier future.
[1] Nature Aging. Implausibility of radical life extension in humans in the twenty-first century
[2] Nature. Life expectancy rise in rich countries slows down: why discovery took 30 years to prove
[3] European Journal of Epidemiology. Healthy lifespan inequality: morbidity compression from a global perspective
